Zhang Guangdi increased his stake in CHAOJU EYE CARE (02219) by 36,000 shares, at a price of HKD 2.358 per share.
The latest number of shares held after the increase is approximately 84,700 shares, with the latest shareholding ratio being 0.01%.
Hong Kong Stock Exchange's latest data shows that on August 31, Zhang Guangdi increased his holding in CHAOJU EYE CARE (02219) by 36,000 shares, at a price of HKD 2.358 per share, totaling approximately HKD 84,900. After the increase, his latest shareholding amounted to about 84,700 shares, with a new ownership ratio of 0.01%.
Related Articles
How to choose AI applications in Hong Kong stocks? DIAGENS-B (02526): A rare vertical AI target with high growth and strong barriers.
Valuation at $2 trillion! Anthropic may become the largest IPO in history, starting its roadshow in October and going public before the mid-term elections in November.
Astrazeneca PLC Sponsored ADR (AZN.US) has received accelerated approval from the FDA for a new breast cancer drug, and Wall Street estimates that sales could reach $2.3 billion by 2032.
How to choose AI applications in Hong Kong stocks? DIAGENS-B (02526): A rare vertical AI target with high growth and strong barriers.
Valuation at $2 trillion! Anthropic may become the largest IPO in history, starting its roadshow in October and going public before the mid-term elections in November.
Astrazeneca PLC Sponsored ADR (AZN.US) has received accelerated approval from the FDA for a new breast cancer drug, and Wall Street estimates that sales could reach $2.3 billion by 2032.
RECOMMEND
